α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C.
Asahina Y; Tsuchiya K; Nishimura T; Muraoka M; Suzuki Y; Tamaki N; Yasui Y; Hosokawa T; Ueda K; Nakanishi H; Itakura J; Takahashi Y; Kurosaki M; Enomoto N; Nakagawa M; Kakinuma S; Watanabe M; Izumi N; Hepatology (Baltimore, Md.), 2013, vol. 58, issue 4, p 1253, ISSN 15273350. ISBN 15273350.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef